Page 430 - Clinical Immunology_ Principles and Practice ( PDFDrive )

410 Part tHrEE Host Defenses to Infectious Agents

function of key components of the spirochete, could lead to 2. Krause RM. Metchnikoff and syphilis research during a decade of
development of single or combination vaccines. Further, the discovery, 1900-1910. Development of an animal model and a
identification of host factors that mediate a protective response preventive treatment set the stage for progress. ASM News
and those that contribute to inflammation may result in a better 1996;62:307–10.
understanding of the disease. Overall, the identification of the 3. Fraser CM, Casjens S, Huang WM, et al. Genomic sequence of
a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997;
elements that mediate specific tissue tropisms for the bacterium 390:580–6.
and their interaction with local/infiltrating cellular components 4. Fraser CM, Norris SJ, Weinstock GM, et al. Complete genome
can permit the design of targeted therapies in conjunction with sequence of Treponema pallidum, the syphilis spirochete. Science
antimicrobial treatments. 1998;281:375–88.
A significant effort is being made to find new antigenic 5. Anguita J, Hedrick M, Fikrig E. Adaptation of Borrelia burgdorferi
determinants that can be the base for a vaccine to prevent infection in the tick and the mammalian host. FEMS Microbiol Rev
with B. burgdorferi. While the search for spirochetal antigens 2003;27:493–504.
continue, a new wave of research has focused on finding antigenic 6. Pal U, Li X, Wang T, et al. TROSPA, an Ixodes scapularis receptor for
determinants that can prevent the efficient attachment of the Borrelia burgdorferi. Cell 2004;119:457–68.
tick vector to the mammalian host, which, in turn, could dampen 7. Hubner A, Yang X, Nolen DM, et al. Expression of Borrelia burgdorferi
OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc
the ability of the arthropod to transmit B. burgdorferi and perhaps Natl Acad Sci USA 2001;98:12724–9.
other pathogens. 8. Center for Disease Control and Prevention. 2016. Available at: https://
For syphilis, the study of the microorganism is hampered by www.cdc.gov/lyme/stats/index.html.
the difficulties associated with its culture and manipulation. 9. Guerau-de-Arellano M, Huber BT. Chemokines and Toll-like receptors in
Although advances have been made in our understanding of the Lyme disease pathogenesis. Trends Mol Med 2005;11:114–20.
pathology associated with infection, a significant challenge in 10. Hawley KL, Olson CM Jr, Iglesias-Pedraz JM, et al. CD14 cooperates with
the near future is to fully understand this pathogen. An area in complement receptor 3 to mediate MyD88-independent phagocytosis of
which advances can be made in the next decade consists of better Borrelia burgdorferi. Proc Natl Acad Sci USA 2012;109:1228–32.
education of populations that are at risk of acquiring the infection. 11. Lawrenz MB, Wooten RM, Zachary JF, et al. Effect of complement
Because these populations are usually associated with low-income component C3 deficiency on experimental Lyme borreliosis in mice.
Infect Immun 2003;71:4432–40.
communities, a significant investment needs to be made to enable 12. Kochi SK, Johnson RC. Role of immunoglobulin G in killing of Borrelia
persons at risk to better evade the transmission of the pathogen, burgdorferi by the classical complement pathway. Infect Immun
through education, better diagnostics, and rapid antimicrobial 1988;56:314–21.
treatment. 13. Madar M, Bencurova E, Mlynarcik P, et al. Exploitation of complement
regulatory proteins by Borrelia and Francisella. Mol Biosyst
2015;11:1684–95.
CONCLUSIONS 14. Pausa M, Pellis V, Cinco M, et al. Serum-resistant strains of Borrelia
Spirochetes are a phylogenetically ancient and distinct group burgdorferi evade complement-mediated killing by expressing a CD59-like
of microorganisms. Because of their propensity to cause complement inhibitory molecule. J Immunol 2003;170:3214–22.
diseases in humans, B. burgdorferi and T. pallidum are the 15. Hovis KM, McDowell JV, Griffin L, et al. Identification and
characterization of a linear-plasmid-encoded factor H-binding protein
two most-well-studied spirochetes. However, the inability to (FhbA) of the relapsing fever spirochete Borrelia hermsii. J Bacteriol
culture T. pallidum in vitro has made researching this spirochete 2004;186:2612–18.
very difficult, and as a consequence, the immune response 16. Garcia BL, Zhi H, Wager B, et al. Borrelia burgdorferi BBK32 inhibits the
that follows infection with this spirochete remains poorly classical pathway by blocking activation of the C1 complement complex.
understood. PLoS Pathog 2016;12:e1005404.
The etiological agents of Lyme disease and syphilis are similar 17. Gross DM, Steere AC, Huber BT. T helper 1 response is dominant and
in that they have relatively small genomes, surviving only in localized to the synovial fluid in patients with Lyme arthritis. J Immunol
association with a host and eliciting inflammatory disease, but 1998;160:1022–8.
genomic comparison clearly shows that T. pallidum and B. 18. Zhang JR, Hardham JM, Barbour AG, et al. Antigenic variation in Lyme
burgdorferi are not closely related. It seems likely that despite disease borreliae by promiscuous recombination of VMP-like sequence
cassettes. Cell 1997;89:275–85.
some similarities, these spirochetes evolved independently from 19. Ramamoorthi N, Narasimhan S, Pal U, et al. The Lyme disease agent
a more complex ancestor, resulting in differences in their life- exploits a tick protein to infect the mammalian host. Nature
cycles, environmental adaptations, and the pathology associated 2005;436:573–7.
with their infection. Therefore it is not surprising to learn of 20. Cox DL, Chang P, McDowall AW, et al. The outer membrane, not a coat
the differences in the host immune responses to B. burgdorferi of host proteins, limits antigenicity of virulent Treponema pallidum.
and T. pallidum. Both the host response to these spirochetes and Infect Immun 1992;60:1076–83.
their infectivity determine the extent of pathology following 21. Salazar JC, Hazlett KR, Radolf JD. The immune response to infection
infection. with Treponema pallidum, the stealth pathogen. Microbes Infect
2002;4:1133–40.
22. Salazar JC, Cruz AR, Pope CD, et al. Treponema pallidum elicits innate
Please check your eBook at https://expertconsult.inkling.com/ and adaptive cellular immune responses in skin and blood during
for self-assessment questions. See inside cover for registration secondary syphilis: a flow-cytometric analysis. J Infect Dis
details. 2007;195:879–87.
23. Blanco DR, Champion CI, Lewinski MA, et al. Immunization with
REFERENCES Treponema pallidum outer membrane vesicles induces high-titer
complement-dependent treponemicidal activity and aggregation of T.
1. Burgdorfer W, Barbour AG, Hayes SF, et al. Lyme disease-a tick-borne pallidum rare outer membrane proteins (TROMPs). J Immunol
spirochetosis? Science 1982;216:1317–19. 1999;163(5):2741–6.